-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q/s6CVT+WWtjAUEqJtpASpR0ZVZrlMDnnfKsMNYpLsXozEhadrpB1oAuWSdV5GZ6 P/M9a7fXNXcXMgAWcHqyAw== 0000892569-03-001155.txt : 20030501 0000892569-03-001155.hdr.sgml : 20030501 20030501142850 ACCESSION NUMBER: 0000892569-03-001155 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030501 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WHEELER MARK M CENTRAL INDEX KEY: 0001229406 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 57 RUE DU DR BLANCHE STREET 2: 75016 CITY: PARIS STATE: I0 ZIP: 00000 BUSINESS PHONE: 01133145245332 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-49329 FILM NUMBER: 03676411 BUSINESS ADDRESS: STREET 1: 157 TECHNOLOGY DR CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9497886700 MAIL ADDRESS: STREET 1: 157 TECHNOLOGY DR CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 SC 13G 1 a89729sc13g.htm SCHEDULE 13G - MARK M. WHEELER M.D. Spectrum Pharmaceuticals Inc
 

OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response...11


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )*

SPECTRUM PHARMACEUTICALS, INC.

(Name of Issuer)

Common Stock, $.001 par value per share

(Title of Class of Securities)

84763A 10 8

(Cusip Number)

November 18, 2002

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

        o Rule 13d-1 (b)

        o Rule 13d-1 (c)

        x Rule 13d-1 (d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).

 

 

             
13G
CUSIP No. 84763A 10 8
  1. Name of Reporting Person:
Mark M. Wheeler, M.D.		 I.R.S. Identification Nos. of above persons (entities only):
N/A
  2. Check the Appropriate Box if a Member of a Group:
    (a) o  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
U.S.A.
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
306,000
6. Shared Voting Power:
0
7. Sole Dispositive Power:
306,000
8.Shared Dispositive Power:
None
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
306,000(1)
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
9.84%
  12.Type of Reporting Person:
IN

2

 

13G
       
Item 1.
  (a) Name of Issuer:
    Spectrum Pharmaceuticals, Inc.
  (b) Address of Issuer’s Principal Executive Offices:
    157 Technology Drive
Irvine, California 92618
 
Item 2.
  (a) Name of Person Filing:
    Mark M. Wheeler, M.D.
  (b) Address of Principal Business Office or, if none, Residence:
    3777 Mt. Zion Road
Upperco, MD 21155
  (c)Citizenship:
    U.S.A.
  (d) Title of Class of Securities:
    Common Stock, $.001 par value per share
  (e) CUSIP Number:
    84763A 10 8
 
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
  (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
  (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
  (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
  (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
  (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  (g) o A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
  (h) o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  (j) o Group, in accordance with §240.13d-1(b)(1)(ii)(J).
 

3

 

13G
       
Item 4. Ownership.
  (a) Amount beneficially owned:
    306,000(1)
  (b) Percent of class:
    9.84%
  (c) Number of shares as to which the person has:
    (i) Sole power to vote or to direct the vote:
      306,000(1)
    (ii) Shared power to vote or to direct the vote:
      0
    (iii) Sole power to dispose or to direct the disposition of:
      306,000
    (iv) Shared power to dispose or to direct the disposition of:
      0
 
Item 5.Ownership of Five Percent or Less of a Class.
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
 
Item 6.Ownership of More than Five Percent on Behalf of Another Person.
 
Not applicable.
 
Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
 
Not applicable.
 
Item 8.Identification and Classification of Members of the Group.
 
Not applicable.
 
Item 9.Notice of Dissolution of Group.
 
Not applicable.

4

 

13G
       
Item 10.Certification.
Not Applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
   
   
   
   
 
Date:  May 1, 2003
   
 
 
/s/ Mark M. Wheeler, M.D.
Name: Mark M. Wheeler, M.D.
 

Footnotes:

(1) Includes 101,000 shares beneficially owned by Dr. Mark Wheeler's wife, Elizabeth H. Wheeler; 9,000 shares beneficially owned by Dr. Mark Wheeler's daughter, Isabelle H. Wheeler, and 34,000 shares subject to a currently exercisable Warrant.

5 -----END PRIVACY-ENHANCED MESSAGE-----